Distribution Agreement

AORTECH INTERNATIONAL PLC 16 September 1999 DISTRIBUTION AGREEMENT WITH MEDOS OF GERMANY AorTech International, ('AorTech') the Scottish based manufacturer of cardiovascular devices, announces that it has concluded a Distribution Agreement with MEDOS, a major cardiovascular device company in Germany. The agreement is for the sale of AorTech's established replacement heart valve products i.e. the Ultracor Mechanical Valve, the Tissue Heart Valve and the Mitral Repair System. Eddie McDaid, AorTech's Managing Director commented: 'We are delighted to have concluded this Distribution Agreement with MEDOS who, with their own cardiovascular devices product range, have a significant market share in Germany. Our core product range is presently marketed in Germany through a restricted number of Open Heart Centres and MEDOS, with their nationwide sales force, will be able to sell our complementary products into the rest of the Open Heart Centres in Germany. The German heart valve replacement market represents approximately 26% of the European market and is the single most important market in Europe and the second most important in the world. This Agreement shows continued acceptance of our product lines.' Karl Heinz Hildinger, Managing Director of MEDOS, which has over 15% of the German cardiopulmonary product market, in sales terms, said: 'We are pleased to have concluded a Distribution Agreement for AorTech's heart valve replacement products which will complement our own cardiovascular device sales in Germany. MEDOS recognises AorTech's products as a quality range of heart valve replacements and anticipate significant sales growth over the next two years.' Enquiries: AorTech International plc Tel: 01698 746699 Eddie McDaid, Managing Director College Hill Tel: 0171 457 2020 Michael Padley Copies of this statement will be available for a period of 14 days from the Company's registered office: Phoenix Crescent, Strathclyde Business Park, Bellshill, Scotland ML4 3NU.
UK 100

Latest directors dealings